Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat

Cancer Science

Volumn 100, Issue 11, 2009, Pages 2022-2027

  Yoshimi, Kazuto ^a   Tanaka, Takuji ^b   Takizawa, Akiko ^a   Kato, Megumi ^c   Hirabayashi, Masumi ^c   Mashimo, Tomoji ^a   Serikawa, Tadao ^a   Kuramoto, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AZOXYMETHANE; BETA CATENIN; DEXTRAN SULFATE; ETHYLNITROSOUREA; GLYCOGEN SYNTHASE KINASE 3BETA; K RAS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MORPHOLOGY; CANCER SUSCEPTIBILITY; COLITIS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; FEMALE; HOMOZYGOSITY; MALE; NONHUMAN; NONSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; RAT; TUMOR LOCALIZATION;

ANIMALS; BETA CATENIN; CODON, NONSENSE; COLITIS; COLONIC NEOPLASMS; ETHYLNITROSOUREA; FEMALE; GENES, APC; MALE; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RATS, INBRED F344;

EID: 71049147574     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01287.x     Document Type: Article

References (34)

1. WHO Media Center, Cancer 2009, Fact sheet No. 297, Geneva, WHO
2. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004, 287:G7-17.
3. Rutter M, Saunders B, Wilkinson K. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004, 126:451-9.
4. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003, 94:965-73.
5. Kohno H, Suzuki R, Sugie S, Tanaka T. β-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate. Cancer Sci 2005, 96:69-76.
6. Tanaka T, Suzuki R, Kohno H, Sugie S, Takahashi M, Wakabayashi K. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess β-catenin gene mutations and increases immunoreactivity for β-catenin, cyclooxygenase-2 and inducible nitric oxide synthase. Carcinogenesis 2005, 26:229-38.
7. Onose J, Imai T, Hasumura M, Ueda M, Hirose M. Rapid induction of colorectal tumors in rats initiated with 1,2-dimethylhydrazine followed by dextran sodium sulfate treatment. Cancer Lett 2003, 198:145-52.
8. Tanaka T, Yasui Y, Tanaka M, Tanaka T, Oyama T, Rahman KMW. Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. Chem Biol Interact 2009, 177:128-36.
9. Kinzler KW, Nilbert MC, Su LK. Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661-5.
10. Suzui M, Okuno M, Tanaka T, Nakagama H, Moriwaki H. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation. Cancer Lett 2002, 183:31-41.
11. Tanaka T, Kohno H, Suzuki R. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer 2006, 118:25-34.
12. Amos-Landgraf JM, Kwong LN, Kendziorski CM. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci USA 2007, 104:4036-41.
13. Mashimo T, Yanagihara K, Tokuda S. An ENU-induced mutant archive for gene targeting in rats. Nat Genet 2008, 40:514-15.
14. Imai Y, Inoue H, Kataoka A. Pael receptor is involved in dopamine metabolism in the nigrostriatal system. Neurosci Res 2007, 59:413-25.
15. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K. β-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 1998, 58:42-6.
16. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004, 95:475-80.
17. Gohma H, Kuramoto T, Kuwamura M. WTC deafness Kyoto (dfk): a rat model for extensive investigations of Kcnq1 functions. Physiol Genomics 2006, 24:198-206.
18. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-4.
19. Couture J, Mitri A, Lagace R. A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 2000, 57:205-12.
20. Matsubara N, Isozaki H, Tanaka N. The farthest 3′ distal end APC mutation identified in attenuated adenomatous polyposis coli with extracolonic manifestations. Dis Colon Rectum 2000, 43:720-1.
21. Morin PJ, Sparks AB, Korinek V. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-90.
22. Urano Y, Asanuma D, Hama Y. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 2009, 15:104-9.
23. Ghirardi M, Nascimbeni R, Villanacci V, Fontana MG, Di Betta E, Salerni B. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth. Eur Surg Res 1999, 31:272-80.
24. Paulsen JE, Loberg EM, Olstorn HB, Knutsen H, Steffensen IL, Alexander J. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Res 2005, 65:121-9.
25. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702.
26. Santiago C, Pagan B, Isidro AA, Appleyard CB. Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer. Cancer Res 2007, 67:10 766-73.
27. Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 2007, 120:3327-35.
28. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994, 54:3676-81.
29. Su LK, Burrell M, Hill DE. APC binds to the novel protein EB1. Cancer Res 1995, 55:2972-7.
30. Matsumine A, Ogai A, Senda T. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 1996, 272:1020-3.
31. McCartney BM, Nathke IS. Cell regulation by the Apc protein: Apc as master regulator of epithelia. Curr Opin Cell Biol 2008, 20:186-93.
32. Hanson CA, Miller JR. Non-traditional roles for the adenomatous polyposis coli (APC) tumor suppressor protein. Gene 2005, 361:1-12.
33. Boismenu R, Chen Y. Insights from mouse models of colitis. J Leukoc Biol 2000, 67:267-78.
34. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005, 206:260-76.